Evidence map›Paper›PMID 36386140›Full record

SynthesisFrontiers in pharmacology2022

Efficacy of PD-1/PD-L1 inhibitors in patients with advanced gastroesophageal cancer: An updated meta-analysis based on randomized controlled trials.

Lihu Gu, Tongmin Huang, Shinan Qiu, Jiaze Hong, Rongrong Fu, Chaoxiong Ni, Senjie Dai, Ping Chen, Ning He

Open access · goldAbstract readSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Lihu GuDepartment of General Surgery, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China.
Tongmin HuangThe Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Shinan QiuMedical School of Ningbo University, Ningbo, Zhejiang, China.
Jiaze HongThe Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Rongrong FuThe First Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Chaoxiong NiDepartment of Nephrology, QingChun Hospital of Zhejiang Province, Hangzhou, Zhejiang, China.
Senjie DaiThe Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Ping ChenDepartment of General Surgery, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China.
Ning HeDepartment of Tumor High-Intensity Focused Ultrasound (HIFU) Therapy, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China.
Zhejiang Chinese Medical University · CNNingbo No. 2 Hospital · CNNingbo University · CNUniversity of Chinese Academy of Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

clinicopathological featuresgastroesophageal cancermeta-analysisPD-1/PD-L1 inhibitorssexsurvival

Identifiers

PMID36386140
PMCPMC9640921
OpenAlexW4307372958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.